Global metabolomics market size is forecast to grow by USD 1.36 billion during 2019-2023 at a CAGR of almost 12%, with biomarker and drug discovery segment having the largest market share. Metabolomics market analysis indicates growth will be driven by rising demand for early and accurate diagnosis. Metabolomics industry growth will also be impacted by its increased applications.

Competitive vendor landscape

The global metabolomics market is highly competitive with major vendors such as Agilent Technologies, Bio-Rad Laboratories, Bruker, Human Metabolome Technologies, and METABOLON, competing on the basis of price, quality, and product/service offerings.

“North America will hold the highest market share of the global metabolomics market throughout the forecast period. The presence of several key vendors is one of the primary reasons for the high growth of the metabolomics market in this region,” says a senior analyst at Technavio

Looking for more information on this market? Request a free sample report

Top five metabolomics market vendors

Agilent Technologies

Agilent Technologies operates in three segments: life sciences and applied markets, diagnostics and genomics, and agilent crosslab. The company’s key offerings include Agilent 7250 GC/Q-TOF system and Seahorse XF Analyzers.

Bio-Rad Laboratories

Bio-Rad Laboratories operates through two segments - life science and clinical diagnostics. The company’s key offerings include: KnowItAll Informatics System. This product is a fully integrated chemistry software and database package, which offers solutions such as search, analysis, structure drawing, and reporting for metabolomics.

Bruker

Bruker operates through two segments: Bruker Scientific Instruments (BSI) and Bruker Energy & Supercon Technologies (BEST). The company’s key offerings include Metabolic Profiler, MALDI Imaging, and MetaboScape.

Human Metabolome Technologies

Human Metabolome Technologies operates through its unified business segment. The company’s key offerings include: Capillary Electrophoresis Mass Spectrometric (CE-MS) platforms and Liquid chromatography-mass spectrometry (LC-MS).

METABOLON

METABOLON operates through its unified business segment. The company’s key offerings include: Complex Lipid Panel, Global Metabolomics, and Precision Metabolomics.